Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Yahoo Finance41minutes ago

$100 Invested In This Stock 20 Years Ago Would Be Worth $4,100 Today

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 20 years by 12.59% on an annualized basis producing an average annual return of 21.02%. Currently, Alnylam

BenzingaJul 18 13:30 ET

Press Release: Alnylam to Webcast Conference Call Discussing Second Quarter 2024 Financial Results

Alnylam to Webcast Conference Call Discussing Second Quarter 2024 Financial Results CAMBRIDGE, Mass.--(BUSINESS WIRE)--July 18, 2024-- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi

Dow JonesJul 18 08:04 ET

Alnylam to Webcast Conference Call Discussing Second Quarter 2024 Financial Results

Alnylam to Webcast Conference Call Discussing Second Quarter 2024 Financial ResultsJul 18, 2024CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jul. 18, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the

Alnylam Pharmaceuticals, Inc.Jul 18 00:00 ET

Peering Into Alnylam Pharmaceuticals's Recent Short Interest

Alnylam Pharmaceuticals's (NYSE:ALNY) short percent of float has risen 72.68% since its last report. The company recently reported that it has 3.68 million shares sold short, which is 3.35% of all

BenzingaJul 17 10:00 ET

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,851,273, According to a Recent SEC Filing

Yvonne Greenstreet, Director, Chief Executive Officer, on July 11, 2024, sold 7,093 shares in Alnylam Pharmaceuticals (ALNY) for $1,851,273. Following the Form 4 filing with the SEC, Greenstreet has

MT NewswiresJul 15 03:05 ET